3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Motor Activity
22
Breast Neoplasms
14
Neoplasms
9
Fatigue
5
Prostatic Neoplasms
4
Obesity
4
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Peripheral Nervous System Diseases
2
Overweight
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lung Neoplasms
2
Cognitive Dysfunction
2
Cardiovascular Diseases
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Smoking
1
Skin Neoplasms
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Osteolysis
1
Non-alcoholic Fatty Liver Disease
1
Neuroectodermal Tumors, Primitive
1
Neurocognitive Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Interventions
Social Determinants of Health
2
Exercise
2
sofosbuvir-velpatasvir drug combination
1
ribociclib
1
palbociclib
1
ibrutinib
1
amlodipine, atorvastatin drug combination
1
acalabrutinib
1
abemaciclib
1
Standard of Care
1
Practice Guidelines as Topic
1
Positron-Emission Tomography
1
Methods
1
Interviews as Topic
1
Hematologic Tests
1
Fish Oils
1
Fatty Acids, Omega-3
1
Electrocardiography
1
Educational Status
1
Echocardiography
1
Early Intervention, Educational
1
Diet
1
Cholecalciferol
1
Chemoradiotherapy
1
Atorvastatin
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Cardiovascular Diseases
×
Exercise
×
Clear all
NCT03748550
2024-08-21
EXACT2
Nova Scotia Health Authority
Phase NA
Active not recruiting
7 enrolled
NCT03424668
2019-04-16
EPIC-Norfolk
University of Cambridge
Active not recruiting
25,639 enrolled